INSIGHTS ON DRUG DEVELOPMENT
-
Highly Sensitive ELISAs In 90 Minutes
Traditional ELISA methods are often limited by their relatively low throughput and need for multiple wash steps. Learn about a solution that overcomes these challenges and provides rapid results.
-
Futurizing Healthcare By Localizing The Life Sciences
Mustapha Bittaye's journey highlights the importance of international funding in fostering local scientific talent and biopharma resilience, empowering research and manufacturing in developing countries.
-
Integrating Phase-Appropriate Quality Standards
Incorporating phase-specific quality standards ensures GMP compliance. Collaborating with an experienced CDMO addresses late-stage quality needs and efficiently manages development timelines.
-
A Digital Dispenser For Single-Cell And Low-Input Proteomics
Discover a high-precision dispensing system that enables rapid, low-volume sample prep for single-cell proteomics to support flexible workflows, maintain cell integrity, and deliver reliable results.
-
A Pharmaceutical Perspective On Generating And Utilizing Multiomic Data4/17/2024
Ratnakar Potla of Genentech explains how Organ-Chips enable scientists to obtain a wider variety of multiomics data to better understand biological processes.
-
Recapitulating Inflammation: How To Use the Colon Intestine-Chip To Study Complex Mechanisms Of IBD4/9/2024
To address the challenges associated with conventional drug development models, a Colon Intestine-Chip has been developed to recapitulate the biology that drives inflammatory bowel disease.
-
What Are Organ-Chips?2/13/2024
Learn in detail about Organ-on-a-Chip technology and how it is paving the way for the next generation of drug development and research.
-
Improving The Efficiency And Quality Of Advanced Imaging And Analysis8/27/2025
Human-relevant models are transforming drug screening. Find out how overcoming 3D cell culture challenges with integrated innovations accelerates discovery and brings effective treatments to patients faster.
-
Next Generation Conjugates: Process And Analytical Challenges3/25/2024
Explore specific examples of challenges commonly encountered in the process and analytical development of next-generation conjugates as well as corresponding solutions for each.
DRUG DEVELOPMENT SOLUTIONS
-
Genedata Profiler empowers biopharma R&D by integrating, harmonizing, and analyzing diverse data, enhancing collaboration, accelerating insights, and reducing costs for precision medicine advancement.
-
Access all the service, support, and performance maintenance options you need for uninterrupted performance – giving your lab more control over your service, maintenance costs, and enabling you to optimize your laboratory productivity.
-
Our integrated approach brings together drug substance, drug product and clinical activities, supporting the expediting of lead molecules from FIH into POC trials.
-
Our expertise and capabilities enable us to meet the complex technical challenges of pediatric products and provide you with a unique integrated development solution.
-
Discover the benefits of partnering with a CDMO that offers expanding capacity and capabilities and a far-reaching operational footprint to support your project.